pefloxacin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khlebnikov, EP; Kubyshkin, VA; Terekhova, RP; Vishnevskiĭ, VA | 1 |
| Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G | 1 |
2 other study(ies) available for pefloxacin and Liver Neoplasms
| Article | Year |
|---|---|
[Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Echinococcosis, Hepatic; Female; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mycoses; Pefloxacin; Postoperative Complications; Treatment Outcome | 2009 |
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam | 1997 |